The Zambia Ivermectin Trial for the Treatment and Prevention of COVID-19

NCT04891250 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Insufficient funding

Conditions

SARS-CoV-2
Ivermectin

Interventions

DRUG: Ivermectin
OTHER: Prophylaxis

Sponsor

Centre for Infectious Disease Research in Zambia

Collaborators

[object Object]
[object Object]